title: [Thermoradiochemotherapy of inoperable soft-tissue sarcoma].
abstract: Three groups of patients with inoperable soft-tissue sarcoma received preoperative radiotherapy (57), thermoradiotherapy (102) and thermoradiochemotherapy (16) (n=175). Five year recurrence-free survival in group 1 was 37+/-7%, group 2 48+/-6%, and group 3 - 56+/-1,7%. Patients survived 5 years and more in group 3 (60+/-2%), group 2 - 50+/-7%, and group I 44+/-8% (p>0.05). Local hyperthermia used in conjunction with radio- and chemoradiotherapy was followed by a significant rise in the rate of complete and partial tumor regression.
authors.forename: S M
authors.initials: SM
authors.lastname: Ivanov
authors.forename: S I
authors.initials: SI
authors.lastname: Tkachev
authors.forename: B Iu
authors.initials: BIu
authors.lastname: Bokhian
authors.forename: N N
authors.initials: NN
authors.lastname: Petrovichev
authors.forename: R M
authors.initials: RM
authors.lastname: Karapetian
authors.forename: G N
authors.initials: GN
authors.lastname: Machak
authors.forename: A V
authors.initials: AV
authors.lastname: Nazarenko
mesh_terms: D000328:Adult; D000368:Aged; D017024:Chemotherapy, Adjuvant / Q000379:methods; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D018714:Radiotherapy, Adjuvant / Q000379:methods; D012509:Sarcoma / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D016896:Treatment Outcome